News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Opinion Editor's Corner Glancing Back, Looking Forward: Lasting Lessons for Years to Come Shelley Wood December 27, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News Correction Issued for Controversial Study Linking COVID-19 Vaccines to ACS Risk Todd Neale December 22, 2021
News Daily News Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis Todd Neale December 16, 2021
News Daily News Large Series Confirms Myocarditis Post-COVID-19 Vax Is Mild in the Young Todd Neale December 10, 2021
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Daily News INTERSTROKE: Anger, Heavy Physical Exertion May Trigger Strokes Todd Neale December 02, 2021
News Daily News Cardiopulmonary Tests Urged for Lasting Fatigue, Dyspnea After COVID-19 Todd Neale December 02, 2021
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Conference News AHA 2021 Racial/Ethnic Disparities in AF Care Persist Despite Dual VA, Medicare Coverage Todd Neale November 19, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Village-Level Intervention Nets Big BP Control Gains in Rural China Todd Neale November 13, 2021